scholarly article | Q13442814 |
P2093 | author name string | Tian Li | |
Wu Yang | |||
Wei Xiao | |||
Shidai Jin | |||
Zhengrong Cai | |||
P2860 | cites work | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 |
Systems biology of cisplatin resistance: past, present and future | Q26863585 | ||
Global cancer statistics, 2012 | Q27860501 | ||
MicroRNA expression profiles classify human cancers | Q28032481 | ||
Many roads to maturity: microRNA biogenesis pathways and their regulation | Q29615469 | ||
Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies | Q30234800 | ||
Wnt signaling pathway pharmacogenetics in non-small cell lung cancer | Q34543360 | ||
MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1. | Q34695651 | ||
MiRNA 17 family regulates cisplatin-resistant and metastasis by targeting TGFbetaR2 in NSCLC. | Q35145398 | ||
The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer | Q35399165 | ||
miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β. | Q35439100 | ||
microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer | Q36424194 | ||
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin | Q36790395 | ||
Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer | Q37013250 | ||
HBx-induced MiR-1269b in NF-κB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells | Q37045394 | ||
Role of microRNA in anticancer drug resistance | Q37563160 | ||
PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature | Q37628937 | ||
Salvianolic acid A positively regulates PTEN protein level and inhibits growth of A549 lung cancer cells | Q37641002 | ||
MicroRNA and drug resistance | Q37751868 | ||
CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells | Q38673081 | ||
Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins | Q38916096 | ||
Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells | Q39137614 | ||
Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cells. | Q39589677 | ||
Knockdown of Dicer in MCF-7 human breast carcinoma cells results in G1 arrest and increased sensitivity to cisplatin. | Q39905313 | ||
Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells. | Q40577530 | ||
Differential expression of microRNAs and their target genes in non-small-cell lung cancer | Q42775779 | ||
Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway | Q47765142 | ||
miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer. | Q52606250 | ||
Advances in the diagnosis and treatment of non-small cell lung cancer. | Q53079706 | ||
MicroRNAs associated with therapy of non-small cell lung cancer. | Q53688073 | ||
TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway | Q90667959 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cisplatin | Q412415 |
non-small-cell lung carcinoma | Q3658562 | ||
P304 | page(s) | 109-118 | |
P577 | publication date | 2020-01-07 | |
P1433 | published in | OncoTargets and Therapy | Q7092081 |
P1476 | title | miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway | |
P478 | volume | 13 |
Search more.